SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8106695
Source:
http://linkedlifedata.com/resource/pubmed/id/8106695
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003593
,
umls-concept:C0023824
,
umls-concept:C0025266
,
umls-concept:C0087111
,
umls-concept:C0205250
,
umls-concept:C0814225
pubmed:issue
4
pubmed:dateCreated
1994-3-24
pubmed:abstractText
Do the benefits of intensive lipid-lowering therapy extend to patients with only borderline or moderately elevated levels of low density lipoprotein (LDL) cholesterol?
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P01 HL 30086
,
http://linkedlifedata.com/resource/pubmed/grant/R01 HL 19451
,
http://linkedlifedata.com/resource/pubmed/grant/RR-37
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL
,
http://linkedlifedata.com/resource/pubmed/chemical/Colestipol
,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Niacin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0735-1097
pubmed:author
pubmed-author:AlberiJ TJT
,
pubmed-author:BrownB GBG
,
pubmed-author:DowdyAA
,
pubmed-author:FisherL DLD
,
pubmed-author:HillgerL ALA
,
pubmed-author:SnidermanA DAD
,
pubmed-author:StewartB FBF
,
pubmed-author:WölkKK
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
899-906
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:8106695-Adult
,
pubmed-meshheading:8106695-Analysis of Variance
,
pubmed-meshheading:8106695-Anticholesteremic Agents
,
pubmed-meshheading:8106695-Apolipoproteins B
,
pubmed-meshheading:8106695-Cholesterol, LDL
,
pubmed-meshheading:8106695-Colestipol
,
pubmed-meshheading:8106695-Coronary Angiography
,
pubmed-meshheading:8106695-Coronary Disease
,
pubmed-meshheading:8106695-Double-Blind Method
,
pubmed-meshheading:8106695-Humans
,
pubmed-meshheading:8106695-Hypercholesterolemia
,
pubmed-meshheading:8106695-Lovastatin
,
pubmed-meshheading:8106695-Male
,
pubmed-meshheading:8106695-Middle Aged
,
pubmed-meshheading:8106695-Niacin
,
pubmed-meshheading:8106695-Treatment Outcome
pubmed:year
1994
pubmed:articleTitle
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
pubmed:affiliation
Department of Medicine, University of Washington School of Medicine, Seattle.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't